News

New oral drug shows high efficacy in HER2-mutated lung cancer

Zongertinib could become a new tool in the treatment of HER-2 mutated lung cancer, specially for an specific group of patients

Leer más about New oral drug shows high efficacy in HER2-mutated lung cancer

New study on the causes of severe COVID-19 in vaccinated patients

A type of autoantibodies is demonstrated to be an independent risk factor for the severity of COVID-19

Leer más about New study on the causes of severe COVID-19 in vaccinated patients

Dr. Roser Velasco, co-lead author of an international guideline on the management of neurological complications in CAR-T cell treatments

Dr. Roser Velasco, IDIBELL principal investigator at Neuro-Oncology group and neurologist at the Neuro-Oncology Unit of ICO Hospitalet and Bellvitge University Hospital, has co-directed the writing of an international guide of recommendations on the management of neurological complications associated with CAR-T cell therapy. Dr. Velasco has participated as an expert in neuro-oncology within the Committee […]

Leer más about Dr. Roser Velasco, co-lead author of an international guideline on the management of neurological complications in CAR-T cell treatments

Gene therapy reverses the symptoms of a rare neurological disease in animal models

Megaloencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare childhood disease that mainly affects the white matter of the brain. Among other symptoms, it is characterized by macrocephaly, inability to coordinate motor movements, and epilepsy. More than 75% of diagnosed cases are due to mutations in the MLC1 gene, which encodes a protein located in […]

Leer más about Gene therapy reverses the symptoms of a rare neurological disease in animal models
Scroll to Top